There is no fulltext present in this item.

Find Full text  
Title: Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM
Author(s): Herbers, A.H.E. ; Velden, W.J.F.M. van der ; Haan, A.F.J. de ; Donnelly, J.P. ; Blijlevens, N.M.A.
Publication year: 2014
Source: Bone Marrow Transplantation, vol. 49, iss. 1, (2014), pp. 8-10
ISSN: 0268-3369
DOI: https://doi.org/10.1038/bmt.2013.118
Publication type: Article / Letter to editor

Please use this identifier to cite or link to this item : https://hdl.handle.net/2066/138238   https://hdl.handle.net/2066/138238

Display more details
Subject: Radboudumc 0: Other Research RIHS: Radboud Institute for Health Sciences
Radboudumc 5: Inflammatory diseases RIMLS: Radboud Institute for Molecular Life Sciences
Radboudumc 9: Rare cancers RIHS: Radboud Institute for Health Sciences
Organization: Haematology
Health Evidence
Journal title:
Bone Marrow Transplantation
Volume: vol. 49
Issue: iss. 1
Page start: p. 8
Page end: p. 10
Abstract:
The matched-control study failed to show a clinical relevant impact of palifermin on intestinal mucositis, although there was a reduced inflammatory response and less febrile neutropenia among patients who had no bacteraemia.

This item appears in the following Collection(s)

Browse

Statistics